We are live on ! Find out more
IRAG

Investment Research & Advisory Group Portfolio holdings

AUM $324M
1-Year Est. Return 22.57%
This Fund
S&P 500
This Quarter Est. Return
+8.68%
1 Year Est. Return
+22.57%
3 Year Est. Return
+88.65%
5 Year Est. Return
+107.32%
10 Year Est. Return
–
AUM
$152M
AUM Growth
+$15.6M
Cap. Flow
+$15.3M
Cap. Flow %
10.11%
Top 10 Hldgs %
53.32%
Holding
183
New
42
Increased
46
Reduced
18
Closed
7

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$12.3M
2
BDX icon
Becton Dickinson
BDX
+$1.37M
3
IVW icon
iShares S&P 500 Growth ETF
IVW
+$704K
4
IVE icon
iShares S&P 500 Value ETF
IVE
+$616K
5
BBEU icon
JPMorgan BetaBuilders Europe ETF
BBEU
+$334K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.3M
2
MA icon
Mastercard
MA
+$153K
3
TSM icon
TSMC
TSM
+$111K
4
PG icon
Procter & Gamble
PG
+$98.8K
5
MCK icon
McKesson
MCK
+$97K

Sector Composition

Rank Sector Weight
1 Financials 19.88%
2 Technology 16.61%
3 Consumer Discretionary 10.76%
4 Healthcare 9.39%
5 Communication Services 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVY icon
76
iShares Select Dividend ETF
DVY
$23.6B
$117K 0.08%
1,000
– –
PTON icon
77
Peloton Interactive
PTON
$2.49B
$117K 0.08%
946
+37
+4% +$3.94K
BBCA icon
78
JPMorgan BetaBuilders Canada ETF
BBCA
$11.3B
$116K 0.08%
+1,794
New +$114K
DKNG icon
79
DraftKings
DKNG
$11.9B
$116K 0.08%
2,232
+15
+0.7% +$791
KO icon
80
Coca-Cola
KO
$375B
$115K 0.08%
2,122
– –
BAC icon
81
Bank of America
BAC
$442B
$114K 0.08%
2,773
+293
+12% +$12K
MDLZ icon
82
Mondelez International
MDLZ
$79.9B
$108K 0.07%
1,725
+118
+7% +$7.27K
IBB icon
83
iShares Biotechnology ETF
IBB
$9.71B
$105K 0.07%
642
– –
ABT icon
84
Abbott
ABT
$187B
$103K 0.07%
888
– –
PNC icon
85
PNC Financial Services
PNC
$101B
$103K 0.07%
538
+50
+10% +$9.38K
BBAX icon
86
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.9B
$102K 0.07%
+1,751
New +$104K
ESGR
87
DELISTED
Enstar Group
ESGR
$102K 0.07%
426
– –
BSV icon
88
Vanguard Short-Term Bond ETF
BSV
$45.6B
$101K 0.07%
1,231
+240
+24% +$19.7K
NKE icon
89
Nike
NKE
$61.9B
$101K 0.07%
655
– –
XYZ
90
Block Inc
XYZ
$47.5B
$98K 0.06%
400
– –
CL icon
91
Colgate-Palmolive
CL
$74.4B
$95K 0.06%
1,171
– –
PENN icon
92
PENN Entertainment
PENN
$2.71B
$93K 0.06%
1,210
– –
O icon
93
Realty Income
O
$59.1B
$91K 0.06%
1,400
– –
BMY icon
94
Bristol-Myers Squibb
BMY
$132B
$87K 0.06%
1,305
+135
+12% +$8.8K
D icon
95
Dominion Energy
D
$59.3B
$86K 0.06%
1,165
– –
GIS icon
96
General Mills
GIS
$19.7B
$83K 0.05%
1,370
– –
CVX icon
97
Chevron
CVX
$366B
$79K 0.05%
757
+54
+8% +$5.7K
EW icon
98
Edwards Lifesciences
EW
$51.7B
$62K 0.04%
600
– –
APD icon
99
Air Products & Chemicals
APD
$67.6B
$60K 0.04%
208
+23
+12% +$6.75K
VGSH icon
100
Vanguard Short-Term Treasury ETF
VGSH
$30.2B
$59K 0.04%
+961
New +$59.1K
2 3
4
5 6

Similar funds

AIA
AIMZ Investment Advisors Los Altos, California $324M AUM 18.77% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
BCP
Bayberry Capital Partners New York $323M AUM 27.31% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $325M AUM 27.67% 1-Year Est. Return
WG
Wellington Group Indianapolis, Indiana $325M AUM
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
DMC
DSC Meridian Capital New York $325M AUM 45.4% 1-Year Est. Return

Investment Research & Advisory Group's Q2 2021 Portfolio in Review

As of Q2 2021, Investment Research & Advisory Group held 183 positions worth $152M, up 11% from $136M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Investment Research & Advisory Group deployed $15.3M of net new capital in Q2 2021, opening 42 new positions and adding to 46 existing holdings. Its largest new stake was iShares S&P 500 Growth ETF: 10,164 shares worth $739K.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Novartis, an estimated $1.3M trimmed.

  • Investment Research & Advisory Group's largest Q2 2021 buy was iShares S&P 500 Growth ETF: 10,164 shares worth $739K.
  • Investment Research & Advisory Group added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $12.3M increase.
  • Investment Research & Advisory Group's biggest Q2 2021 reduction was Novartis, cutting an estimated $1.3M.
  • Investment Research & Advisory Group fully exited McKesson in Q2 2021, selling an estimated $97K.
  • Investment Research & Advisory Group's ten largest holdings make up 53% of its $152M portfolio in Q2 2021.
  • Investment Research & Advisory Group opened 42 new positions and closed 7 in Q2 2021.
  • Investment Research & Advisory Group's portfolio value rose 11% quarter-over-quarter to $152M.

Based on Investment Research & Advisory Group's 13F filing for Q2 2021, filed 29 Jul 2021.